Objective: Human macrophage metalloelastase is referred to as matrix metalloproteinase (MMP-12), its function in tumors is contradictory. The current study was undertaken to investigate the role of MMP-12 in esophageal squamous cell carcinoma (SCC). Patients and Methods: We analyzed the levels of MMP-12 mRNA expression in 67 patients with primary esophageal SCC by Northern blot analysis and the tissues were subjected to in situ hybridization analysis for MMP-12. Immunohistochemical staining was performed to detect the macrophages infiltrated in esophageal SCCs. Results: MMP-12 mRNA was detected in 27 of 67 esophageal SCC samples by Northern blot analysis. In situ hybridization and immunohistochemical staining revealed that MMP-12 mRNA signals are located mainly in tumor cells. The frequency of lymph node metastasis was significantly higher in the MMP-12-positive (MMP-12(+)) subgroup than MMP-12-negative (MMP-12(-)) subgroup (p ! 0.05); furthermore, invasion was significantly deeper in the MMP-12(+) subgroup than in the MMP-12(-) subgroup (p ! 0.01). MMP-12 mRNA was inversely correlated with prognosis (p ! 0.05). However, Cox multivariate analysis revealed that upregulation of MMP-12 was not related to prognosis. Conclusions: MMP-12 gene expression was associated with the progression of esophageal SCC; however, it was not an independent prognostic factor.
Introduction
Esophageal carcinoma is one of the most aggressive tumors and its growth is relatively rapid. In particular, the presence of lymph node metastasis and vascular invasion indicate a highly malignant potential in esophageal carcinoma [1] . In general, esophageal carcinoma has a poor prognosis compared with other gastrointestinal tumors unless intensive therapy is given. The 5-year survival rate is 20-30% after curative surgery [2] . The reason for this poor prognosis is that esophageal cancer exhibits extensive local invasion or frequent regional lymph node metastasis, even at the time of initial diagnosis. Tumor invasion and metastasis involve degradation of different components of the extracellular matrix and require the actions of proteolytic enzymes such as matrix metalloproteinase (MMPs), produced either by the tumor cells themselves or by surrounding stromal cells. It therefore seems evident that MMPs play an important role in tumor invasion and metastasis [3] [4] [5] [6] . Elastin is the major component of elastic fibers and provides resilience to tissues exposed to dynamic stress. Macrophage metalloelastase (MMP-12) was first identified as an elastolytic metalloproteinase secreted by activated macrophages [7] . Besides elastase activity, MMP-12 displays broad substrate specificity, including extracellular matrix, proteins such as fibronectin, laminin, vitronectin, type IV collagen and heparan sulfate; MMP-12 also generates angiostatin from plasminogen [8, 9] .
Until now, there have been few reports about MMP-12 in tumors, and the function of MMP-12 in tumors is contradictory. Gorrin-Rivas et al. [10] found MMP-12 was expressed in human hepatocellular carcinoma and was significantly associated with angiostatin secretion by such tumors, furthermore, they confirmed that mouse macrophage metalloelastase gene transferred into a murine melanoma suppressed primary tumor growth by halting angiogenesis [11] . MMP-12 gene overexpression in colorectal carcinoma was closely correlated with a better prognosis [12] . In contrast, Kerkela et al. [13] found that MMP-12 expression in skin cancer correlated with epithelial dedifferentiation and histologic aggressiveness. In human brain tumors, anaplastic astrocytomas and grade IV glioblastomas expressed significantly higher levels MMP-12 than grade I meningiomas [14] . Recently, Salmela et al. [15] found esophageal adenocarcinoma expressed MMP-12 in tumor-infiltrating macrophages. However, MMP-12 expression in esophageal squamous cell carcinoma (SCC) has not been demonstrated.
In this study, we have investigated gene expression level and tissue location of MMP-12, and studied whether MMP-12 plays an important role in esophageal SCC progression.
Materials and Methods

Tissue Samples
From 1994 to 2000, surgical specimens were obtained from 67 patients with esophageal carcinoma who underwent surgery at the Kyoto University Hospital. All patients underwent resection of the primary tumor. None of the patients received chemotherapy or radiotherapy. Histological studies were performed by the clinicopathological department of the hospital and all the tumors were confirmed to be esophageal SCC. Tumor and adjacent normal mucosa were collected and stored at -80°C until used. Written informed consent was obtained from all patients for surgery and use of their resected samples. Primary cancers of the esophagus were classified according to the pathological tumor node metastasis (pTNM) classification [16] . Twenty-one esophageal cancer cell lines (KYSE series) used in this study were established in our laboratory [17] .
In situ Hybridization Analysis
Sense and antisense RNA probes and in situ hybridization were performed as described previously [10] . Briefly, sections were dewaxed with chloroform and rehydrated through a graded series of ethanol concentrations: 100, 90, 80, and 70% ethanol. All sections were pretreated with 20 Ìg/ml of proteinase K and 0.2 N HCl to inactivate the tissue alkaline phosphatase, and 0.25% acetic anhydride in 0.1 M triethanolamine-HCl. Sections were hybridized with digoxigenin-labeled antisense RNA probe at 55°C for 16 h. The hybridized digoxigenin-labeled probes were detected by using a Nucleic Acid Detection Kit (Boehringer Mannheim, Indianapolis, Ind., USA) following the manufacturer's instructions. Nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate were used as chromogens. Hybridization with the sense probe at the same time under identical conditions served as the negative control.
RNA Extraction and Northern Blot Hybridization
Total RNA was isolated from tumor and adjacent normal mucosa using the same method as described previously [10] . Twenty micrograms of total RNA from each human tissue sample was electrophoresed on 1.0% agarose-formaldehyde gel and transferred to a Hybond-N+ Nylon membrane filter (Amersham International plc, UK). The probes were labeled with [· 32 P]-deoxycitidine 5) triphosphate by using the Megaprime Random-Primer DNA Labeling kit (Amersham). Hybridization was performed at 65°C for 2 h in Rapid Hybridization Buffer (Amersham) with a labeled probe. After hybridization, the filters were washed twice with 2 ! SSC and 0.1% SDS at room temperature for 10 min, once with 1 ! SSC and 0.1% SDS at 65°C for 20 min. The membranes were rehybridized with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) DNA probe as an internal control. The amount of MMP-12 mRNA was determined by densitometric scanning of autoradiograms with an ATTO Densitograph (ATTO Corporation, Tyoko, Japan) and normalized to GAPDH mRNA. The MMP-12 mRNA levels in the paired tumor and adjacent normal mucosa from the same patient were quantified and the ratio of the former to the latter was then defined as the MMP-12 tumor/nontumor (T/N) ratio.
Immunohistochemistry
Immunohistochemical staining was performed on sections parallel to those used for in situ hybridization. Tissue sections were deparaffinized and rehydrated in water. Endogenous peroxidase was blocked with 0.3% hydrogen peroxide for 30 min. After pretreatmet with trypsin (5 mg/ml) at 37°C for 20 min, sections were rehydrated and washed with phosphate-buffered saline (PBS) and incubated with 1.5% normal horse serum in PBS for 30 min at room temperature to block nonspecific antibody reaction. Sections were incubated overnight at 4°C with horseradish-peroxidase-conjugated anti-human CD68 antibody (clone PG-M1, DAKO, Denmark) diluted 1:100 in PBS containing 1% bovine serum albumin. After 6 rinses in PBS, the sections were incubated in 0.03% 3,3)-diaminobenzidine tetrahydrochloride as chromogen for 5 min. The sections were counterstained with Mayer's hematoxylin. Negative controls, prepared by substituting normal mouse serum for the primary antibody, resulted in no detectable staining.
Ding/Shimada/Gorrin-Rivas/Itami/Li/ Hong/Maeda/Komoto/Kawabe/Kaganoi/ Imamura Northern blot hybridization analysis for MMP-12 mRNA expression from 6 representative patients with esophageal SCC. Top, MMP-12 mRNA expression in esophageal SCC (T) and adjacent normal mucosa (N). Bottom, the same membranes were striped and rehybridized with a probe to GAPDH as an internal control. Human placenta (PL) was used as a positive control. In 4 cases (case 2, 3, 4, 6) MMP-12 mRNA expression in the tumorous portions was exclusively elevated. In contrast, the adjacent normal mucosa in all 4 cases showed no signal for MMP-12. In 1 case (case 1) MMP-12 mRNA expression was strongly detected in the tumorous portion, conversely, the nontumorous tissues showed a weak signal for MMP-12. In 1 case (case 5), no MMP-12 mRNA expression was detected in both the tumorous portion and the adjacent normal mucosa.
Statistical Analysis
Fisher's exact test or Pearson's ¯2 test of equality were used to compare clinicopathologic background and MMP-12 mRNA levels. Survival analysis was calculated by the Kaplan-Meier method and analyzed by the log rank test. Multivariate analysis was performed by the Cox proportional hazards model. The software used was JMP version 4. p ! 0.05 was considered to be statistically significant.
Results
MMP-12 Messenger RNA Expressions in Tumor and Adjacent Normal Mucosa from the Patients with Esophageal SCC
Northern blot analysis was used to examine MMP-12 gene expression in both tumor and adjacent normal mucosa from 67 patients with esophageal SCC. Representative results of the Northern blot analysis were shown in figure 1 . A 1.8-kb band, corresponding to the MMP-12 transcript, was detected in the tumorous tissues in 27 of the 67 esophageal SCCs (40.3%). In all of the 27 cases, the MMP-12 mRNA levels in tumorous tissues were higher than those in adjacent normal mucosa (T/N 11.2). In contrast, the adjacent normal mucosa showed no signal or very faint signals for MMP-12. T/N values of the tumors ranged from 0.76 to 19.30. All investigated esophageal carcinoma cell lines hardly expressed MMP-12 mRNA, based on Northern blot analysis (data not shown).
Identification of MMP-12-Producing Cells
To identify the cells responsible for the signals shown in Northern blot analysis, in situ hybridization was performed in 12 cases with esophageal SCC. MMP-12 mRNA was detected in 6/12 tumors, which was consistent with the result of Northern blot analysis. The MMP-12 mRNA transcripts were observed mainly in esophageal SCC cells in the central and also in the marginal areas of the tumor nests with a homogeneous staining pattern. In contrast, the normal esophageal squamous epithelium, smooth muscle cells and endothelial cells were not stained. No significant staining was seen in the sections hybridized at the same time with the sense probe as a negative control ( fig. 2a-d) . Immunostaining of CD68, which is a macrophage marker, was to exclude the possibility that MMP-12 expressing cells in esophageal SCC were macrophages. The staining demonstrated that a few of the MMP-12 positive cells were macrophages located both in the tumor islands and near borders of tumor islands ( fig. 2e) 
Correlation between MMP-12 mRNA Expression and Clinicopathological Features of the Patients
To evaluate the relationship of MMP-12 mRNA expression levels with the clinicopathological factors of patients with esophageal SCC, 67 patients were divided into the two following subgroups: 27 patients with MMP-12 T/N ratio greater than 1.2, and 40 with a ratio less than or equal to 1.2. For the purpose of discrimination, the terms MMP-12(+) and MMP-12(-) were coined to describe each of the subgroups, respectively. It should be pointed out that the subgroup with a ratio less than or equal to 1.2 means that there is no expression of MMP-12 gene in the tumorous tissues because there were no cases showing stronger expression levels of MMP-12 mRNA in the adjacent normal mucosa than in the tumorous tissues. As shown in table 1, 21 of 27 cases with MMP-12(+) showed lymph node metastasis, whereas 19 of 40 cases with MMP-12(-) showed lymph node metastasis; a significant difference was observed between the two subgroups (p ! 0.05). With regard to the depth of invasion there was significant difference between the two subgroups (p ! 0.01) as well. No significant differences were seen regarding age, sex, histological differentiation and lymphatic permeation between the two subgroups. The patients whose tumors did not show MMP-12 mRNA expression showed a better survival rate than those whose tumors showed MMP-12 mRNA expression by the log rank test (p = 0.025) ( fig. 3 ). Multivariate analysis revealed that pN [risk ratio (RR) 7.50, confidence interval (CI) 2.41-33.00)] was a prognostic factor; age, gender, pT, histological differentiation and MMP-12 expression were not prognostic factors (table 2) .
Discussion
Degradation and remodeling of the surrounding basement membrane and extracellular matrix are crucial events in tumor invasion [6] . Various MMPs might form a network, in which each MMP has a distinct role and their activation would happen in a cascade-like manner [18] . MMPs in esophageal carcinoma were reported on MMP-2, MMP-3, MMP-7, MMP-11, MMP-13 to be crucial for tumor invasion, lymph node metastasis, and relapse-free survival [19] [20] [21] [22] . However, the significance of MMP-12 in esophageal SCC has not been studied.
We investigated a series of 67 archival specimens of esophageal SCC; MMP-12 mRNA was demonstrated to be expressed in 27 carcinoma tissues as compared with the corresponding normal esophageal mucosa from the esophagus. In previous studies, most MMPs in carcinoma tissues were primarily expressed in stromal cells; in esophageal adenocarcinoma, MMP-12 was expressed by a subset of macrophages [15] . However, in this study, MMP-12 mRNA was expressed predominantly in esophageal SCC, consistent with skin cancer [13] , hepatocellular carcinoma [10] and colorectal carcinoma [12] , only a few of the MMP-12 positive cells were macrophages located both in the tumor islands and near the borders of tumor islands.
Among various other MMPs, MMP-12 has been suggested to be antiangiogenic, as it generates angiostatin from plasminogen [9, 23] . Angiostatin inhibits endothelial cell proliferation and metastasis tumor cell growth, and it can be speculated that more invasive tumors express less MMP-12. Indeed, Gorrin-Rivas et al. [10] found that those hepatocellular carcinoma patients whose tumors did not express MMP-12 mRNA had a less favorable prognosis than those whose tumors expressed large amounts of MMP-12. One reason why the function of MMP-12 in esophageal SCC was the opposite of that in hepatocellular carcinoma and colorectal carcinoma is perhaps that lymph node metastasis plays a more important role than angiogenesis in esophageal SCC; another reason is that maybe there is less plasminogen in esophageal SCC than in hepatocellular carcinoma and colorectal carcinoma, so there is little angiostatin in esophageal SCC.
MMP-12 displays broad substrate specificity, including ECM proteins such as fibronectin, laminin, vitronectin, type IV collagen. Thus MMP-12 not only digests elastin and plasminogen but also degrades some components of the basement membrane. Furthermore, macrophages of MMP-12 -/-mice displayed a markedly diminished capacity to degrade extracellular matrix components [24] . MMP-12 -/-macrophages were essentially unable to penetrate basement membrane both in vitro and in vivo. Therefore it is postulated that MMP-12 is perhaps is associated with tumor invasion and metastasis. In fact, Kachra et al. [14] found that anaplastic astrocytomas and grade IV glioblastomas expressed significantly higher levels of MMP-12 than grade I meningiomas, and Kerkela et al. [13] noted that both protein and mRNA of MMP-12 were expressed more in less differentiated SCC. In agreement with the results of Kerkela et al., we detected that esophageal SCCs which expressed high amounts of MMP-12 mRNA led to metastasis more easily than those without MMP-12 expression (p ! 0.05). The more esophageal SCC expressed MMP-12 mRNA, the deeper it invaded the wall of esophagus (p ! 0.05). Overall survival rate was significantly worse in the subgroup highly expressing MMP-12 mRNA than in the subgroup not expressing MMP-12 mRNA. In this study, MMP-12 gene expression was not an independent prognostic factor, it should be regarded as preliminary due to the small number of cases investigated.
All investigated 21 esophageal carcinoma cell lines hardly expressed MMP-12 mRNA. This pattern greatly differed from the results of surgical samples, which indicates that MMP-12 expression in esophageal SCC was not completely independent of the stromal component, and that some stromal-derived factor might stimulate the expression. Our preliminary study showed that coculture with esophageal fibroblasts could not induce MMP-12 expression in esophageal SCC cell lines, therefore, other mesenchymal cells may induce MMP-12 expression in esophageal SCC.
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In conclusion, our analysis revealed that esophageal SCC expressed MMP-12 mRNA, and that MMP-12 was associated with esophageal SCC lymph node metastasis and invasion, but that it was not an independent prognostic factor. In addition, inhibition of MMP-12 using MMP-12 antagonizers may help control the spread of esophageal carcinoma.
